Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate

In a recent randomized, double-blind, placebo-controlled trial, we established a robust efficacy (Cohen’s d = 2.17) of osmotic release oral system-methylphenidate (OROS-methylphenidate) delivered 72 mg daily for 5 weeks versus placebo on attention deficit hyperactivity disorder (ADHD) symptoms, glob...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginsberg, Ylva, Hirvikoski, Tatja, Grann, Martin, Lindefors, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491195/
https://www.ncbi.nlm.nih.gov/pubmed/22526730
http://dx.doi.org/10.1007/s00406-012-0317-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491195/
https://www.ncbi.nlm.nih.gov/pubmed/22526730
http://dx.doi.org/10.1007/s00406-012-0317-8

Ejemplares similares